Spontaneous bacterial peritonitis (SBP) is an acute inflammatory disease developing in the abdominal cavity, characterized by infection of the peritoneal fluid without an obvious source of infection within the abdominal cavity. This condition is usually observed in patients with ascites, often due to liver cirrhosis or other concomitant diseases. SBP is a significant complication that requires timely diagnosis and adequate treatment, since its progression can lead to significant consequences, including high mortality.
History of the disease and interesting historical facts
Spontaneous bacterial peritonitis was first described in the 1970s when physicians noted that some patients with ascites developed peritonitis without an obvious source of bacterial infection. Studies have shown that the most common causes of infection are gram-negative bacteria such as Escherichia coli and Klebsiella pneumoniae. Since its first reported case, the disease has been the subject of intense research aimed at elucidating its pathogenesis, diagnostic methods, and treatment. Interest in SBP has increased with advances in both diagnostic and therapeutic technologies, which have improved the prognosis for patients with the disease. Some data suggest that by saving lives in these patients, the development of antibacterial therapy and the use of peritoneal catheters have helped reduce early mortality.
Epidemiology
Spontaneous bacterial peritonitis remains a serious medical problem, especially in patients with ascites. According to statistics, SBP is diagnosed in approximately 10-20% adults with ascites caused by liver cirrhosis. The incidence rate varies depending on the region and other factors. One study shows that in countries with a high prevalence of viral hepatitis and liver cirrhosis, the incidence rate can reach 30% or more. Mortality from SBP also remains high, ranging from 20% to 50%, which emphasizes the need for timely diagnosis and treatment. However, given modern methods of therapy and monitoring, mortality has tended to decrease in recent decades.
Genetic predisposition to this disease
Although spontaneous bacterial peritonitis is primarily an infectious disease, some investigators have considered the possibility of a genetic predisposition to this condition. Certain mutations in genes involved in the immune response could increase the risk of developing SBP, particularly in patients with pre-existing liver disease. For example, there is evidence of involvement of genes encoding components of the immune defense system, such as Toll-like receptors (TLRs), which play an important role in the pathogenesis of infections. Therefore, the study of genetic factors and mutations may be an important direction in the future to understand the mechanisms that contribute to spontaneous bacterial peritonitis.
Risk factors for the development of this disease
Risk factors for developing spontaneous bacterial peritonitis include:
- The presence of ascites, often associated with liver cirrhosis.
- Immunodeficiency states, including viral infections such as HIV.
- Liver cirrhosis, especially decompensated, which increases the likelihood of bacterial overgrowth in ascitic fluid.
- Use of diuretics, which can affect the composition and distribution of fluid in the body.
- Previous episodes of peritonitis or other infections.
These factors contribute to the disruption of the barrier function of the peritoneal cavity and create favorable conditions for the infectious process.
Diagnosis of this disease
Diagnosis of spontaneous bacterial peritonitis involves a comprehensive approach consisting of:
- Main symptoms: Characteristic manifestations may include fever, abdominal pain, increasing weakness, and abnormal tenderness when palpating the abdomen.
- Laboratory tests: Detection of bacterial infection in ascitic fluid is performed using paracentesis for cytology analysis and bacterial culture.
- Radiologic examinations: Ultrasound may be used to assess the presence of ascites and the possibility of other complications.
- Other diagnostic tests may include a CT scan to examine the abdominal cavity in more detail.
- Differential diagnosis: Other causes of acute abdominal pain must be excluded, including acute pancreatitis, cholecystitis, and other abdominal infections.
Conducting these studies allows for diagnosis and appropriate treatment to be initiated at an early stage.
Treatment
Treatment of spontaneous bacterial peritonitis should be prompt and begins immediately after diagnosis. It includes:
- General treatment: primarily includes antibacterial therapy aimed at eliminating the pathogenic microorganism.
- Pharmacological treatment: Most commonly used are broad-spectrum antibiotics such as cefotaxime or piperacillin with tadobactam depending on the sensitivity of the microorganisms.
- Surgical treatment: may be necessary in cases of complications such as perforation or acute inflammation of the abdominal organs.
- Other treatments: supportive measures such as the use of Albumin to correct hypoalbuminemia and improve the hemodynamic situation.
This multi-stage treatment can significantly increase the chances of a successful outcome.
List of medications used to treat this disease
The main medications for the treatment of spontaneous bacterial peritonitis include:
- Cefotaxime.
- Piperacillin with tadobactam.
- Ceftriaxone.
- Gentamicin.
- Oxacillin.
These drugs should be selected taking into account the sensitivity of pathogenic microorganisms to ensure maximum treatment effectiveness.
Disease monitoring
Monitoring the condition of a patient with spontaneous bacterial peritonitis includes regular control stages aimed at assessing the clinical effectiveness of the therapy:
- Control stages: require repeated analysis of ascitic fluid and laboratory tests for the presence of infectious parameters.
- Prognosis: With timely initiation of treatment, the prognosis for life is improved, but the risk of relapse remains.
- Complications: May include shock, sepsis and long-term health effects, especially in patients with chronic liver disease.
Adequate monitoring and control of patient conditions plays a key role in reducing morbidity and mortality.
Age-related features of the disease
Spontaneous bacterial peritonitis has its own characteristics depending on the age group:
- In elderly patients: the disease is more severe, often associated with concomitant pathologies and associated risk factors.
- In young people: Cases are more often associated with viral infections and are less common among people without pre-existing conditions.
- In children: cases are extremely rare, however, in the presence of severe liver disease, the risk of developing SBP should be carefully monitored.
Understanding age-related characteristics allows us to adapt approaches to diagnosis and treatment.
Questions and Answers
- What is spontaneous bacterial peritonitis? Spontaneous bacterial peritonitis is an infectious inflammatory disease of the abdominal cavity that often develops in patients with ascites.
- What are the main symptoms of spontaneous bacterial peritonitis? The main symptoms include fever, abdominal pain, abdominal distension and a general feeling of weakness.
- How is spontaneous bacterial peritonitis diagnosed? Diagnosis includes ascitic fluid analysis, laboratory tests, radiological examinations and differential diagnosis.
- What is the treatment for spontaneous bacterial peritonitis? Treatment includes antibacterial therapy, supportive measures, and, in case of complications, surgical intervention.
- What is the prognosis for spontaneous bacterial peritonitis? The prognosis depends on the timeliness of treatment, but mortality can reach 20-50% without treatment.
